Inari Medical, Inc. (NARI) Tops Q4 EPS by 12c, Revenues Beat; Offers 1Q & FY21 Revenues Guidance Above Consensus

Go back to Inari Medical, Inc. (NARI) Tops Q4 EPS by 12c, Revenues Beat; Offers 1Q & FY21 Revenues Guidance Above Consensus
(NASDAQ: NARI) Delayed: 79.97 --0 (-0%)
Previous Close $79.97    52 Week High
Open $79.97    52 Week Low
Day High $79.97    P/E N/A 
Day Low $79.97    EPS
Volume 3,000